Literature DB >> 10581239

Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.

I Ohki1, N Shimotake, N Fujita, M Nakao, M Shirakawa.   

Abstract

CpG methylation in vertebrates is important for gene silencing, alterations in chromatin structure and genomic stability, and differences in the DNA-methylation status are correlated with imprinting phenomena, carcinogenesis and embryonic development. Methylation signals are interpreted by protein factors that contain shared methyl-CpG-binding domains (MBDs). We have determined the solution structure of the MBD of the human methylation-dependent transcriptional repressor MBD1 by multi-dimensional heteronuclear NMR spectroscopy. It folds into an alpha/beta-sandwich structure with characteristic loops. Basic residues conserved in the MBD family are largely confined to one face of this fold and a flexible loop, which together form a large positively charged surface. Site-directed mutagenesis and chemical shift changes upon complexing with a methylated DNA facilitated identification of this surface as the DNA interaction site. In addition to three basic residues, conserved Tyr34 and Asp32 were shown to be important for the DNA binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581239      PMCID: PMC1171728          DOI: 10.1093/emboj/18.23.6653

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery.

Authors:  N K Kaludov; A P Wolffe
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

Review 2.  DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease.

Authors:  A El-Osta; A P Wolffe
Journal:  Gene Expr       Date:  2000

3.  Functional consequences of Rett syndrome mutations on human MeCP2.

Authors:  T M Yusufzai; A P Wolffe
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  Mismatch repair in methylated DNA. Structure and activity of the mismatch-specific thymine glycosylase domain of methyl-CpG-binding protein MBD4.

Authors:  Peiying Wu; Chen Qiu; Anjum Sohail; Xing Zhang; Ashok S Bhagwat; Xiaodong Cheng
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

Review 5.  Eukaryotic methyl-CpG-binding domain proteins and chromatin modification.

Authors:  Ming-Shiu Hung; C-K James Shen
Journal:  Eukaryot Cell       Date:  2003-10

6.  Epigenetic programming of the rRNA promoter by MBD3.

Authors:  Shelley E Brown; Moshe Szyf
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

Review 7.  Understanding paternal genome demethylation through live-cell imaging and siRNA.

Authors:  Kazuo Yamagata; Yuki Okada
Journal:  Cell Mol Life Sci       Date:  2011-01-15       Impact factor: 9.261

8.  Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.

Authors:  S Kudo; Y Nomura; M Segawa; N Fujita; M Nakao; C Schanen; M Tamura
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

9.  From endonucleases to transcription factors: evolution of the AP2 DNA binding domain in plants.

Authors:  Enrico Magnani; Kimmen Sjölander; Sarah Hake
Journal:  Plant Cell       Date:  2004-08-19       Impact factor: 11.277

Review 10.  DNA methylation and methyl-CpG binding proteins: developmental requirements and function.

Authors:  Ozren Bogdanović; Gert Jan C Veenstra
Journal:  Chromosoma       Date:  2009-06-09       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.